|
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma
|
Ongoing
|
Rituximab/ SAIT101
|
3
|
AGB 002
|
Prince Sultan Military Medical City (Riyadh), King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
|
|
"A PHASE 2/3, MULTICENTER, MULTINATIONAL,OPEN-LABEL STUDY TO EVALUATE THE EFFICACY ANDSAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUMCOFACTOR DEFICIENCY (MOCD) TYPE A"
|
Ongoing
|
ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate)
|
2b
|
ALXN1101-MCD-202
|
King Fahad Medical City (Riyadh)
|
|
A Phase 4, Double-Blind, Randomised, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction with Surgery in Subjects with Moderate to Severe Hidradenitis Suppurativa
|
Ongoing
|
Adalimumab
|
4
|
M15-574
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors
|
Ongoing
|
-
|
4
|
WI210066
|
King Fahad Medical City (Riyadh)
|
|
Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia
|
Ongoing
|
canagliflozin
|
4
|
28431754DI
|
Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah)
|
|
Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia
|
Ongoing
|
Consta
|
4
|
RRA-19315
|
Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar)
|
|
The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study
|
Ongoing
|
Tigecycline
|
4
|
RAC#216103
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial
|
Ongoing
|
All SFDA already registered Antibiotics
|
4
|
CT 15/022
|
King Abdulaziz Medical City NG (Riyadh)
|
|
ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE
|
Ongoing
|
Dabigatran etexilate
|
4
|
1160.188
|
King Salman Bin AbdulAziz Hospital
|
|
Forxiga (dapagliflozin) Post Authorization Safety Study
|
Ongoing
|
Forxiga
|
4
|
D1690R0003
|
King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah)
|
